Growth arrest by the cyclin-dependent kinase inhibitor p27(Kip)1 is abrogated by c-Myc

EMBO Journal

Volumn 15, Issue 23, 1996, Pages 6595-6604

  Vlach, Jaromir ^a   Hennecke, Silke ^a   Alevizopoulos, Konstantinos ^a   Conti, Daniela ^a   Amati, Bruno ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

CDK; CKI; Cyclin; Myc; p27

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; GENE PRODUCT; PROTEIN KINASE INHIBITOR; RETINOBLASTOMA PROTEIN; UBIQUITIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DEPHOSPHORYLATION; DIMERIZATION; DNA BINDING; ENZYME INHIBITION; GENE EXPRESSION; MITOGENESIS; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; RAT; RETROVIRUS; TRANSCRIPTION INITIATION; VIRUS RECOMBINANT;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0029822745     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb01050.x     Document Type: Article

References (79)

1. Alexandrow, M.G., Kawabata, M., Aakre, M. and Moses, H.L. (1995) Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor β1. Proc. Natl Acad. Sci. USA, 92, 3239-3243.
2. Amati, B. and Land, H. (1994) Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev., 4, 102-108.
3. Amati, B., Dalton, S., Brooks, M.W., Littlewood, T.D., Evan, G.I. and Land, H. (1992) Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature, 359, 423-426.
4. Amati, B., Brooks, M.W., Levy, N., Littlewood, T.D., Evan, G.I. and Land, H. (1993a) Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell, 72, 233-245.
5. Amati, B., Littlewood, T.D., Evan, G.I. and Land, H. (1993b) The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J., 12, 5083-5087.
6. Armelin, H.A., Armelin, M.C., Kelly, K., Stewart, T., Leder, P., Cochran, B.H. and Stiles, C.D. (1984) Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature, 310, 655-660.
7. Barone, M.V. and Courtneidge, S.A. (1995) Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature, 378, 509-512.
8. Beijersbergen, R.L., Carlee, L., Kerkhoven, R.M. and Bernards, R. (1995) Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev., 9, 1340-1353.
9. Clurman, B.E., Sheaff, R.J., Thress, K., Groudine, M. and Roberts, J.M. (1996) Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev., 10, 1979-1990.
10. Coats, S., Flanagan, W.M., Nourse, J. and Roberts, J.M. (1996) Requirement of p27(kip1) for restriction point control of the fibroblast cell cycle. Science, 272, 877-880.
11. DeGregori, J., Kowalik, T. and Nevins, J.R. (1995) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol., 15, 4215-4224.
12. Desbarats, L., Gaubatz, S. and Eilers, M. (1996) Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev., 10, 447-460.
13. Eilers, M., Schirm, S. and Bishop, J.M. (1991) The MYC protein activates transcription of the α-prothymosin gene. EMBO J., 10, 133-141.
14. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-Myc protein. Cell, 69, 119-128.
15. Fero, M.L. et al. (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(kip1)-deficient mice. Cell, 85, 733-744.
16. Firpo, E., Koff, A., Solomon, M.J. and Roberts, J.M. (1994) Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol., 14, 4889-4901.
17. Galaktionov, K., Chen, X. and Beach, D. (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature, 382, 511-517.
18. Guan, K.L., Jenkins, C.W., Li, Y., Nichols, M.A., Wu, X., O'Keefe, C.L., Matera, A.G. and Xiong, Y. (1994) Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8, 2939-2952.
19. Hannon, G.J. and Beach, D. (1994) p15 INK4B is a potential effector of TGFβ-induced growth arrest. Nature, 371, 257-261.
20. Hanson, K.D., Shichiri, M., Follansbee, M.R. and Sedivy, J.M. (1994) Effects of c-myc expression on cell cycle progression. Mol. Cell. Biol., 14, 5748-5755.
21. Harper, J.W. and Elledge, S.J. (1996) Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev., 6, 56-64.
22. Harrington, E.A., Bennett, M.R., Fanidi, A. and Evan, G.I. (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13, 3286-3295.
23. Hengst, L. and Reed, S.I. (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science, 271, 1861-1864.
24. Hengst, L., Dulic, V., Slingerland, J.M., Lees, E. and Reed, S.I. (1994) A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl Acad. Sci. USA, 91, 5291-5295.
25. Henriksson, M. and Lüscher, B. (1996) Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68, 109-182.
26. Hermeking, H., Funk, J.O., Reichert, M., Ellwart, J.W. and Eick, D. (1995) Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene, 11, 1409-1415.
27. Herrera, R.E., Sah, V.P., Williams, B.O., Makela, T.P., Weinberg, R.A. and Tyler, J. (1996) Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in rb-deficient fibroblasts. Mol. Cell. Biol., 16, 2402-2407.
28. Hirai, H., Roussel, M.F., Kato, J.Y., Ashmun, R.A. and Sherr, C.J. (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15, 2672-2681.
29. Jansen-Dürr, P., Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, J., Wessbecher J., Draetta, G. and Eilers, M. (1993) Differential modulation of cyclin gene expression by MYC. Proc. Natl Acad. Sci. USA, 90, 3685-3689.
30. Kato, G.J., Barrett, J., Villa, G.M. and Dang, C.V. (1990) An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol., 10, 5914-5920.
31. Kato, J.Y., Matsuoka, M., Polyak, K., Massague, J. and Sherr, C.J. (1994) Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell, 79, 487-496.
32. Kawamata, N. et al. (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55, 2266-2269.
33. Kearsey, J.M., Coates, P.J., Prescott, A.R., Warbrick, E. and Hall, P.A. (1995) Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene, 11, 1675-1683.
34. Keath, E.J., Caimi, P.G. and Cole, M.D. (1984) Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell, 39, 339-348.
35. Kiyokawa, H. et al. (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(kip1). Cell, 85, 721-732.
36. Li, Y., Graham, C., Lacy, S., Duncan, A.M. and Whyte, P. (1993) The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev., 7, 2366-2377.
37. Mal, A., Poon, R.Y.C., Howe, P.H., Toyoshima, H., Hunter, T. and Harter M.L. (1996) Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature, 380, 262-265.
38. Marcu, K.B., Bossone, S.A. and Patel A.J. (1992) myc function and regulation. Annu. Rev. Biochem., 61, 809-860.
39. Mayol X., Garriga, J. and Grana, X. (1995) Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene, 11, 801-808.
40. Minami, Y., Kono, T., Miyazaki, T. and Taniguchi, T. (1993) The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol., 11, 245-268.
41. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134.
42. Morgenstern, J.P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18, 3587-3596.
43. Morosetti, R., Kawamata, N., Gombart, A.F., Miller, C.W., Hatta, Y., Hirama, T., Said, J.W., Tomonaga, M. and Koeffler, H.P. (1995) Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood, 86, 1924-1930.
44. Müller, R. (1995) Transcriptional regulation during the mammalian cell cycle. Trends Genet., 11, 173-178.
45. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Hori, I., Loh, D.Y. and Nakayama, K. (1996) Mice lacking p27(kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85, 707-720.
46. Nourse, J., Firpo, E., Flanagan, W.M., Coats, S., Polyak, K., Lee, M.H., Massagué, J., Crabtree, G. and Roberts, J. (1994) Interleukin-2-mediated elimination of p27 Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature, 372, 570-573.
47. Pagano, M., Tam, S.W., Theodoras, A.M., Beer, R.P., Del, S.G., Chau, V., Yew, P.R., Draetta, G.F. and Rolfe, M. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science, 269, 682-685.
48. Pardee, A.B. (1989) G1 events and regulation of cell proliferation. Science, 246, 603-608.
49. Pear, W.S., Nolan, G.P., Scott, M.L. and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA, 90, 8392-8396.
50. Pietenpol, J.A. et al. (1995) Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res., 55, 1206-1210.
51. Polyak, K., Kato, J.Y., Solomon, M.J., Sherr, C.J., Massague, J., Roberts, J.M. and Koff, A. (1994a) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
52. Polyak, K., Lee, M.H., Erdjument, B.H., Koff, A., Roberts, J.M., Tempst, P. and Massague, J. (1994b) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals, Cell, 78, 59-66.
53. Ponce-Castaneda, M.V. et al. (1995) p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55, 1211-1214.
54. Poon, R.Y.C., Toyoshima, H. and Hunter, T. (1995) Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin and ultraviolet irradiation. Mol. Biol. Cell, 6, 1197-1213.
55. Quelle, D.E. et al. (1995) Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene, 11, 635-645.
56. Rapp, U.R., Cleveland, J.L., Brightman, K., Scott, A. and Ihle, J.N. (1985) Abrogation of Il-3 and Il-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes. Nature, 317, 434-438.
57. Renno, T., Hahne, M. and MacDonald, R. (1995) Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J. Exp. Med., 181, 2283-2287.
58. Reynisdottir, I., Polyak, K., Iavarone, A. and Massague, J. (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9, 1831-1845.
59. Roussel, M.F. Cleveland, J.L., Shurtleff, S.A. and Sherr, C.J. (1991) Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature, 353, 361-363.
60. Roussel, M.F., Theodoras, A.M., Pagano, M. and Sherr, C.J. (1995) Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl Acad. Sci. USA, 92, 6837-6841.
61. Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Müller, R., Ansorge, W. and Eilers, M. (1996) Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J., 15, 3065-3076.
62. Schulze, A., Zerfass, K., Spitkovsky, D., Middendorp, S., Berges, J., Helin, K., Jansen, D.P. and Henglein, B. (1995) Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl Acad. Sci. USA, 92, 11264-11268.
63. Sherr, C.J. (1993) Mammalian G1 cyclins. Cell, 73, 1059-1065.
64. Sherr, C.J. (1994) G1 phase progression: cycling on cue. Cell, 79, 551-555.
65. Sherr, C.J. (1995) D-type cyclins. Trends Biochem. Sci., 20, 187-190.
66. Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
67. Slingerland, J.M., Hengst, L., Pan, C.H., Alexander, D., Stampfer, M.R. and Reed, S.I. (1994) A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol., 14, 3683-3694.
68. Soos, T.J. et al. (1996) Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ., 7, 135-146.
69. 1 cyclin-cdk complexes. EMBO J., 14, 4814-4826.
70. Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D.A. and el-Houseini, M.E. (1994) Induction of p21 (WAF-1/CIP1) during differentiation. Oncagene, 9, 3389-3396.
71. Stone, J., de Lange, T., Ramsay, G., Jakobvits, E., Bishop, J.M., Varmus, H. and Lee, W. (1987) Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol., 7, 1697-1709.
72. Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
73. Vairapandi, M., Balliet, A.G., Fornace, A.J.J., Hoffman, B. and Liebermann, D.A. (1996) The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1. Oncogene, 12, 2579-2594.
74. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
75. Weinberg, R.A. (1996) E2F and cell proliferation: a world turned upside down. Cell, 85, 457-459.
76. Won, K.-A. and Reed, S.I. (1996) Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J., 15, 4182-4193.
77. Xiao, Z.-X., Ginsberg, D., Ewen, M. and Livingston, D.M. (1996) Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc. Natl Acad. Sci. USA, 93, 4633-4637.
78. Zetterberg, A., Larsson, O. and Wiman, K.G. (1995) What is the restriction point? Curr. Opin. Cell Biol., 7, 835-842.
79. Zhan, Q. et al. (1994) The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol. Cell. Biol., 14, 2361-2371.